Today, there were numerous reports on the International Federation of Pharmaceutical Manufacturers & Associations’ (IFPMA.org) release of their new guidelines for industry practices.  I applaud the group and note their guidelines now seem to be in agreement with the most recent PhRMA guidelines.  Obviously, this is a step in the right direction, but the concern is, does it help the image of our industry?  Does it raise the level of trust? Continue reading →